
Adjuvant Letrozole Extends Benefits in Breast Cancer to Postmenopausal Women Regardless of HR Status or Age
Author(s) -
Mark Fuerst
Publication year - 2007
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000298599.13115.4a
Subject(s) - letrozole , tamoxifen , medicine , breast cancer , aromatase , aromatase inhibitor , estrogen receptor , oncology , adjuvant therapy , immunohistochemistry , progesterone receptor , gynecology , cancer